Stroke

Cardiovascular departments are playing a role in stroke interventions at numerous health systems, working as part of the stroke care team with neurologists, radiology and the emergency department. Stroke first has be be classified as ischemic or hemorrhagic. These have very different care pathways. Ischemic strokes are increasingly being treated with neurological-interventional therapy that includes catheter based mechanical thrombectomy to remove the clot. This is a more aggressive treatment compared to traditional IV administration of tissue plasminogen activator (tPA) thrombolytic therapy to dissolve the clot. Subarachnoid hemorrhage (SAH) and intracerebral hemorrhage (ICH) brain bleeds can also be treated in some cases stent flow diverters and embolization coils.

FDA clears intravascular device billed as ‘world’s smallest camera’ as physicians share new data
The new device, which provides users with real-time images in full color, is now approved by the FDA to be used in the peripheral vasculature. Meanwhile, first-in-human data published in Stroke explored its potential in the cerebral vasculature.
FDA clears new large-bore catheter for challenging stroke cases
The newly cleared device was built to provide support, trackability and stability during the treatment of time-sensitive stroke patients.
Medtronic to acquire medtech company Scientia Vascular for $550M
Scientia Vascular, a Salt Lake City-based medtech company focused on developing new vascular devices, was founded in 2007 and has more than 300 employees.
Johnson & Johnson launches 3 new stroke devices
These devices were developed to help clinicians reach and remove distal clots associated with significant pain and swelling. If left untreated, such clots can lead to medical emergencies and even death.
GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms
When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater.

Male stroke patients undergo CTA at significantly higher rates than women with no impact on outcomes

The disparity appeared concentrated among white, privately insured, higher income, and middle aged (50-79 year-old) men.

Abbott recalls delivery sheath for LAA occluder device after 16 injuries

The FDA has categorized this as a Class I recall, which means using the devices “may cause serious injuries or death.”

Conformal Medical raises $35M to continue development, research of next-gen LAAO device

The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.

Incomplete neurovascular imaging work-ups to blame for subsequent stroke in patients with TIA

Up to 37% of patients presenting with transient ischemic attack do not receive a full neurovascular imaging work-up, according to new data published in the American Journal of Roentgenology.

Physical activity is linked to smaller brain bleeds, new CT data reveal

The research, published in Stroke and Vascular Neurology, suggests that just four hours of physical activity per week can reduce the significance of a brain bleed.

Number of stroke deaths worldwide could reach nearly 5 million by 2030

The worldwide stroke rate has been decreasing over time, but the population is aging and growing at such a rapid rate that stroke-related mortality is still expected to rise.

Industry first: FDA clears device for detecting stroke on noncontrast CT

RapidAI said it aims to give smaller facilities access to tools often only available at comprehensive stroke centers.

Explainable stroke AI cleared for US sales

The FDA has OK’d a new artificial intelligence platform for quickly diagnosing stroke on unenhanced CT scans.

Stroke

FDA clears intravascular device billed as ‘world’s smallest camera’ as physicians share new data

FDA clears new large-bore catheter for challenging stroke cases

Medtronic to acquire medtech company Scientia Vascular for $550M

Johnson & Johnson launches 3 new stroke devices

GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms